Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1990 Oct;65(10 Spec No):1082–1088. doi: 10.1136/adc.65.10_spec_no.1082

Bronchopulmonary dysplasia: early diagnosis, prophylaxis, and treatment.

A Greenough 1
PMCID: PMC1590250  PMID: 2241232

Full text

PDF
1082

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abman S. H., Accurso F. J., Koops B. L. Experience with home oxygen in the management of infants with bronchopulmonary dysplasia. Clin Pediatr (Phila) 1984 Sep;23(9):471–476. doi: 10.1177/000992288402300901. [DOI] [PubMed] [Google Scholar]
  2. Albersheim S. G., Solimano A. J., Sharma A. K., Smyth J. A., Rotschild A., Wood B. J., Sheps S. B. Randomized, double-blind, controlled trial of long-term diuretic therapy for bronchopulmonary dysplasia. J Pediatr. 1989 Oct;115(4):615–620. doi: 10.1016/s0022-3476(89)80297-5. [DOI] [PubMed] [Google Scholar]
  3. Avery G. B., Fletcher A. B., Kaplan M., Brudno D. S. Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics. 1985 Jan;75(1):106–111. [PubMed] [Google Scholar]
  4. Avery M. E., Tooley W. H., Keller J. B., Hurd S. S., Bryan M. H., Cotton R. B., Epstein M. F., Fitzhardinge P. M., Hansen C. B., Hansen T. N. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics. 1987 Jan;79(1):26–30. [PubMed] [Google Scholar]
  5. Bancalari E., Gerhardt T. Bronchopulmonary dysplasia. Pediatr Clin North Am. 1986 Feb;33(1):1–23. doi: 10.1016/s0031-3955(16)34967-7. [DOI] [PubMed] [Google Scholar]
  6. Bland R. D., Kim M. H., Light M. J., Woodson J. L. High frequency mechanical ventilation in severe hyaline membrane disease an alternative treatment? Crit Care Med. 1980 May;8(5):275–280. doi: 10.1097/00003246-198005000-00001. [DOI] [PubMed] [Google Scholar]
  7. Block E. R., Fisher A. B. Prevention of hyperoxic-induced depression of pulmonary serotonin clearance by pretreatment with superoxide dismutase. Am Rev Respir Dis. 1977 Sep;116(3):441–447. doi: 10.1164/arrd.1977.116.3.441. [DOI] [PubMed] [Google Scholar]
  8. Bonikos D. S., Bensch K. G., Northway W. H., Jr Oxygen toxicity in the newborn. The effect of chronic continuous 100 percent oxygen exposure on the lungs of newborn mice. Am J Pathol. 1976 Dec;85(3):623–650. [PMC free article] [PubMed] [Google Scholar]
  9. Cummings J. J., D'Eugenio D. B., Gross S. J. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med. 1989 Jun 8;320(23):1505–1510. doi: 10.1056/NEJM198906083202301. [DOI] [PubMed] [Google Scholar]
  10. Donn S. M., Faix R. G., Banagale R. C. Dexamethasone for bronchopulmonary dysplasia. Lancet. 1983 Aug 20;2(8347):460–460. doi: 10.1016/s0140-6736(83)90429-4. [DOI] [PubMed] [Google Scholar]
  11. Doshi N., Kanbour A., Fujikura T., Klionsky B. Tracheal aspiration cytology in neonates with respiratory distress: histopathologic correlation. Acta Cytol. 1982 Jan-Feb;26(1):15–21. [PubMed] [Google Scholar]
  12. Durie P. R., Forstner G. G., Gaskin K. J., Moore D. J., Cleghorn G. J., Wong S. S., Corey M. L. Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency. Pediatr Res. 1986 Mar;20(3):209–213. doi: 10.1203/00006450-198603000-00002. [DOI] [PubMed] [Google Scholar]
  13. Edwards D. K., Dyer W. M., Northway W. H., Jr Twelve years' experience with bronchopulmonary dysplasia. Pediatrics. 1977 Jun;59(6):839–846. [PubMed] [Google Scholar]
  14. Ehrenkranz R. A., Ablow R. C., Warshaw J. B. Prevention of bronchopulmonary dysplasia with vitamin E administration during the acute stages of respiratory distress syndrome. J Pediatr. 1979 Nov;95(5 Pt 2):873–878. doi: 10.1016/s0022-3476(79)80457-6. [DOI] [PubMed] [Google Scholar]
  15. Ehrenkranz R. A., Bonta B. W., Ablow R. C., Warshaw J. B. Amelioration of bronchopulmonary dysplasia after vitamin E administration. A preliminary report. N Engl J Med. 1978 Sep 14;299(11):564–569. doi: 10.1056/NEJM197809142991102. [DOI] [PubMed] [Google Scholar]
  16. Engelhardt B., Elliott S., Hazinski T. A. Short- and long-term effects of furosemide on lung function in infants with bronchopulmonary dysplasia. J Pediatr. 1986 Dec;109(6):1034–1039. doi: 10.1016/s0022-3476(86)80295-5. [DOI] [PubMed] [Google Scholar]
  17. Fitzhardinge P. M., Eisen A., Lejtenyi C., Metrakos K., Ramsay M. Sequelae of early steroid administration to the newborn infant. Pediatrics. 1974 Jun;53(6):877–883. [PubMed] [Google Scholar]
  18. Frank L., Lewis P. L., Sosenko I. R. Dexamethasone stimulation of fetal rat lung antioxidant enzyme activity in parallel with surfactant stimulation. Pediatrics. 1985 Mar;75(3):569–574. [PubMed] [Google Scholar]
  19. Goldman S. L., Gerhardt T., Sonni R., Feller R., Hehre D., Tapia J. L., Bancalari E. Early prediction of chronic lung disease by pulmonary function testing. J Pediatr. 1983 Apr;102(4):613–617. doi: 10.1016/s0022-3476(83)80202-9. [DOI] [PubMed] [Google Scholar]
  20. Greenough A., Elias-Jones A., Pool J., Morley C. J., Davis J. A. The therapeutic actions of theophylline in preterm ventilated infants. Early Hum Dev. 1985 Oct;12(1):15–22. doi: 10.1016/0378-3782(85)90132-x. [DOI] [PubMed] [Google Scholar]
  21. Greenough A., Greenall F., Gamsu H. Synchronous respiration: which ventilator rate is best? Acta Paediatr Scand. 1987 Sep;76(5):713–718. doi: 10.1111/j.1651-2227.1987.tb10554.x. [DOI] [PubMed] [Google Scholar]
  22. Greenough A., Greenall F. Performance of respirators at fast rates commonly used in neonatal intensive care units. Pediatr Pulmonol. 1987 Sep-Oct;3(5):357–361. doi: 10.1002/ppul.1950030512. [DOI] [PubMed] [Google Scholar]
  23. Greenough A., Milner A. D. High frequency ventilation in the neonatal period. Eur J Pediatr. 1987 Sep;146(5):446–449. doi: 10.1007/BF00441591. [DOI] [PubMed] [Google Scholar]
  24. Greenough A., Pool J., Gamsu H. Randomised controlled trial of two methods of weaning from high frequency positive pressure ventilation. Arch Dis Child. 1989 Jun;64(6):834–838. doi: 10.1136/adc.64.6.834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Greenough A., Pool J., Greenall F., Morley C., Gamsu H. Comparison of different rates of artificial ventilation in preterm neonates with respiratory distress syndrome. Acta Paediatr Scand. 1987 Sep;76(5):706–712. doi: 10.1111/j.1651-2227.1987.tb10553.x. [DOI] [PubMed] [Google Scholar]
  26. Greenough A., Roberton N. R. Morbidity and survival in neonates ventilated for the respiratory distress syndrome. Br Med J (Clin Res Ed) 1985 Feb 23;290(6468):597–600. doi: 10.1136/bmj.290.6468.597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Gunn T., Reece E. R., Metrakos K., Colle E. Depressed T cells following neonatal steroid treatment. Pediatrics. 1981 Jan;67(1):61–67. [PubMed] [Google Scholar]
  28. Hallman M., Merritt T. A., Jarvenpaa A. L., Boynton B., Mannino F., Gluck L., Moore T., Edwards D. Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial. J Pediatr. 1985 Jun;106(6):963–969. doi: 10.1016/s0022-3476(85)80253-5. [DOI] [PubMed] [Google Scholar]
  29. Hallman M., Spragg R., Harrell J. H., Moser K. M., Gluck L. Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J Clin Invest. 1982 Sep;70(3):673–683. doi: 10.1172/JCI110662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Heicher D. A., Kasting D. S., Harrod J. R. Prospective clinical comparison of two methods for mechanical ventilation of neonates: rapid rate and short inspiratory time versus slow rate and long inspiratory time. J Pediatr. 1981 Jun;98(6):957–961. doi: 10.1016/s0022-3476(81)80604-x. [DOI] [PubMed] [Google Scholar]
  31. Hird M., Greenough A., Gamsu H. Gas trapping during high frequency positive pressure ventilation using conventional ventilators. Early Hum Dev. 1990 Apr;22(1):51–56. doi: 10.1016/0378-3782(90)90025-e. [DOI] [PubMed] [Google Scholar]
  32. Hufnagle K. G., Khan S. N., Penn D., Cacciarelli A., Williams P. Renal calcifications: a complication of long-term furosemide therapy in preterm infants. Pediatrics. 1982 Sep;70(3):360–363. [PubMed] [Google Scholar]
  33. Hyde I., English R. E., Williams J. D. The changing pattern of chronic lung disease of prematurity. Arch Dis Child. 1989 Apr;64(4 Spec No):448–451. doi: 10.1136/adc.64.4_spec_no.448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Johnson L., Bowen F. W., Jr, Abbasi S., Herrmann N., Weston M., Sacks L., Porat R., Stahl G., Peckham G., Delivoria-Papadopoulos M. Relationship of prolonged pharmacologic serum levels of vitamin E to incidence of sepsis and necrotizing enterocolitis in infants with birth weight 1,500 grams or less. Pediatrics. 1985 Apr;75(4):619–638. [PubMed] [Google Scholar]
  35. Kao L. C., Durand D. J., Phillips B. L., Nickerson B. G. Oral theophylline and diuretics improve pulmonary mechanics in infants with bronchopulmonary dysplasia. J Pediatr. 1987 Sep;111(3):439–444. doi: 10.1016/s0022-3476(87)80476-6. [DOI] [PubMed] [Google Scholar]
  36. Kao L. C., Warburton D., Cheng M. H., Cedeño C., Platzker A. C., Keens T. G. Effect of oral diuretics on pulmonary mechanics in infants with chronic bronchopulmonary dysplasia: results of a double-blind crossover sequential trial. Pediatrics. 1984 Jul;74(1):37–44. [PubMed] [Google Scholar]
  37. Kao L. C., Warburton D., Platzker A. C., Keens T. G. Effect of isoproterenol inhalation on airway resistance in chronic bronchopulmonary dysplasia. Pediatrics. 1984 Apr;73(4):509–514. [PubMed] [Google Scholar]
  38. Kao L. C., Warburton D., Sargent C. W., Platzker A. C., Keens T. G. Furosemide acutely decreases airways resistance in chronic bronchopulmonary dysplasia. J Pediatr. 1983 Oct;103(4):624–629. doi: 10.1016/s0022-3476(83)80602-7. [DOI] [PubMed] [Google Scholar]
  39. Konishi M., Fujiwara T., Naito T., Takeuchi Y., Ogawa Y., Inukai K., Fujimura M., Nakamura H., Hashimoto T. Surfactant replacement therapy in neonatal respiratory distress syndrome. A multi-centre, randomized clinical trial: comparison of high- versus low-dose of surfactant TA. Eur J Pediatr. 1988 Jan;147(1):20–25. doi: 10.1007/BF00442605. [DOI] [PubMed] [Google Scholar]
  40. Lenney W., Milner A. D. At what age do bronchodilator drugs work? Arch Dis Child. 1978 Jul;53(7):532–535. doi: 10.1136/adc.53.7.532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. MOYER W. T. Vitamin E levels in term and premature newborn infants. Pediatrics. 1950 Dec;6(6):893–896. [PubMed] [Google Scholar]
  42. McCann E. M., Lewis K., Deming D. D., Donovan M. J., Brady J. P. Controlled trial of furosemide therapy in infants with chronic lung disease. J Pediatr. 1985 Jun;106(6):957–962. doi: 10.1016/s0022-3476(85)80252-3. [DOI] [PubMed] [Google Scholar]
  43. Merritt T. A., Stuard I. D., Puccia J., Wood B., Edwards D. K., Finkelstein J., Shapiro D. L. Newborn tracheal aspirate cytology: classification during respiratory distress syndrome and bronchopulmonary dysplasia. J Pediatr. 1981 Jun;98(6):949–956. doi: 10.1016/s0022-3476(81)80603-8. [DOI] [PubMed] [Google Scholar]
  44. Mitchell A., Greenough A., Hird M. Limitations of patient triggered ventilation in neonates. Arch Dis Child. 1989 Jul;64(7 Spec No):924–929. doi: 10.1136/adc.64.7_spec_no.924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Najak Z. D., Harris E. M., Lazzara A., Jr, Pruitt A. W. Pulmonary effects of furosemide in preterm infants with lung disease. J Pediatr. 1983 May;102(5):758–763. doi: 10.1016/s0022-3476(83)80253-4. [DOI] [PubMed] [Google Scholar]
  46. Ng P. C., Thomson M. A., Dear P. R. Dexamethasone and infection in preterm babies: a controlled study. Arch Dis Child. 1990 Jan;65(1 Spec No):54–56. doi: 10.1136/adc.65.1_spec_no.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Noble-Jamieson C. M., Regev R., Silverman M. Dexamethasone in neonatal chronic lung disease: pulmonary effects and intracranial complications. Eur J Pediatr. 1989 Jan;148(4):365–367. doi: 10.1007/BF00444135. [DOI] [PubMed] [Google Scholar]
  48. Northway W. H., Jr, Rosan R. C., Porter D. Y. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967 Feb 16;276(7):357–368. doi: 10.1056/NEJM196702162760701. [DOI] [PubMed] [Google Scholar]
  49. Reynolds E. O., Taghizadeh A. Improved prognosis of infants mechanically ventilated for hyaline membrane disease. Arch Dis Child. 1974 Jul;49(7):505–515. doi: 10.1136/adc.49.7.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Robinson M. J., Maayan C., Eyal F. G., Armon Y., Bar-Yishay E., Godfrey S. Does the pattern of ventilation determine the degree of lung damage following intensive care of the newborn? Isr J Med Sci. 1982 Aug;18(8):835–839. [PubMed] [Google Scholar]
  51. Rooklin A. R., Moomjian A. S., Shutack J. G., Schwartz J. G., Fox W. W. Theophylline therapy in bronchopulmonary dysplasia. J Pediatr. 1979 Nov;95(5 Pt 2):882–888. doi: 10.1016/s0022-3476(79)80459-x. [DOI] [PubMed] [Google Scholar]
  52. Rosan R. C. Hyaline membrane disease and a related spectrum of neonatal pneumopathies. Perspect Pediatr Pathol. 1975;2:15–60. [PubMed] [Google Scholar]
  53. Rosenfeld W., Evans H., Concepcion L., Jhaveri R., Schaeffer H., Friedman A. Prevention of bronchopulmonary dysplasia by administration of bovine superoxide dismutase in preterm infants with respiratory distress syndrome. J Pediatr. 1984 Nov;105(5):781–785. doi: 10.1016/s0022-3476(84)80307-8. [DOI] [PubMed] [Google Scholar]
  54. Rosenfeld W., Evans H., Jhaveri R., Moainie H., Vohra K., Georgatos E., Salazar J. D. Safety and plasma concentrations of bovine superoxide dismutase administered to human premature infants. Dev Pharmacol Ther. 1982;5(3-4):151–161. [PubMed] [Google Scholar]
  55. Saldanha R. L., Cepeda E. E., Poland R. L. The effect of vitamin E prophylaxis on the incidence and severity of bronchopulmonary dysplasia. J Pediatr. 1982 Jul;101(1):89–93. doi: 10.1016/s0022-3476(82)80193-5. [DOI] [PubMed] [Google Scholar]
  56. Shenai J. P., Kennedy K. A., Chytil F., Stahlman M. T. Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. J Pediatr. 1987 Aug;111(2):269–277. doi: 10.1016/s0022-3476(87)80086-0. [DOI] [PubMed] [Google Scholar]
  57. Sherman M. P., Goetzman B. W., Ahlfors C. E., Wennberg R. P. Tracheal asiration and its clinical correlates in the diagnosis of congenital pneumonia. Pediatrics. 1980 Feb;65(2):258–263. [PubMed] [Google Scholar]
  58. Wilkie R. A., Bryan M. H. Effect of bronchodilators on airway resistance in ventilator-dependent neonates with chronic lung disease. J Pediatr. 1987 Aug;111(2):278–282. doi: 10.1016/s0022-3476(87)80087-2. [DOI] [PubMed] [Google Scholar]
  59. Yuksel B., Greenough A., Maconochie I. Effective bronchodilator treatment by a simple spacer device for wheezy premature infants. Arch Dis Child. 1990 Jul;65(7):782–785. doi: 10.1136/adc.65.7.782. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES